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SchizophreniaBackground: Sleep dysfunction is extremely common in patients with schizophrenia. Recent research indicates
that sleep dysfunction may contribute to psychotic experiences such as delusions and hallucinations.
Objectives: The review aims to evaluate the evidence for a relationship between sleep dysfunction and individual
psychotic experiences, make links between the theoretical understanding of each, and highlight areas for future
research.
Method: A systematic search was conducted to identify studies investigating sleep and psychotic experiences
across clinical and non-clinical populations.
Results: 66 papers were identiﬁed. This literature robustly supports the co-occurrence of sleep dysfunction and
psychotic experiences, particularly insomnia with paranoia. Sleep dysfunction predicting subsequent psychotic
experiences receives support from epidemiological surveys, research on the transition to psychosis, and relapse
studies. There is also evidence that reducing sleep elicits psychotic experiences in non-clinical individuals, and
that improving sleep in individuals with psychosis may lessen psychotic experiences. Anxiety and depression
consistently arise as (partial) mediators of the sleep and psychosis relationship.
Conclusion: Studies are needed that: determine the types of sleep dysfunction linked to individual psychotic ex-
periences; establish a causal connection between sleep and psychotic experiences; and assess treatments for
sleep dysfunction in patients with non-affective psychotic disorders such as schizophrenia.
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Psychotic disorders such as schizophrenia have been associatedwith
sleep dysfunction since ﬁrst clinically described. In case study descrip-
tions Kraepelin (1919) frequently refers to disturbed sleep and suggests
that in treatment “Rest in bed, supervision, care for sleep and food, are
here the most important requisites” (p. 279). Bleuler (1950) also
noted that sleep disturbances were common in psychosis: “Sleep is ha-
bitually disturbed... Many patients do not want to sleep because they
want to know what goes on during the night, or because they fear
some violence to themselves while asleep” (p. 59). Patient accounts
similarly show awareness of an interaction between their psychotic ex-
periences and their sleep: “They [the voices] keep me from going to
sleep”; “the more tired I am the worse they get” (Waite et al., 2015).
However, it is only in the last few years that a research agenda has
emerged concerning sleep dysfunction as a putative contributory
causal factor and therapeutic target in the occurrence of psychotic expe-
riences (Freeman, Pugh, Vorontsova, & Southgate, 2009; Freeman &
Waite et al., 2015; Harvey & Murray, 2011; Wulff, Gatti, Wettstein, &
Foster, 2010).
Outside of the clinical realm a literature exists showing the effects of
sleep deprivation on individuals in the general population. Small studies
carried out in the 1950s and 1960s reported that sleep deprivation in
otherwise healthy individuals leads to emergence of psychotic-like ex-
periences, such as hallucinations, with the frequency and severity of
these experiences increasing with time spent awake (Bliss, Clark, &
West, 1959; Brauchi & West, 1959; Katz & Landis, 1935; Luby,
Frohman, Grisell, Lenzo, & Gottlieb, 1960; Pasnau, Naitoh, Stier, &
Kollar, 1968; Ross, 1965; West & Janszen, 1962). Illustrative descrip-
tions from these studies include: “He saw a ﬁne smoke begin to rise
from the ﬂoor….as he stared at the ﬂoor more closely, ﬁne jets of
water appeared to be rising” (Bliss et al., 1959) and: “During the course
of the vigil Z [attributed] persecutory intent to one of the experimenters.
He became more and more certain that this experimenter was person-
ally interested in making life disagreeable for him” (Katz & Landis,
1935) Intriguingly, one experimental study found that 100h ofwakeful-
ness was associated with a resurgence or exaggeration of psychotic
symptoms in a small sample (n = 6) of inpatients with schizophrenia
(Koranyi & Lehmann, 1960).
In this review we revisit the link between disrupted sleep and indi-
vidual psychotic experiences, in particular delusions and hallucinations.
We set out to answer the question of whether psychotic experiences
and sleep dysfunction are related, and if so, how. After reviewing the
existing research addressing these questions we will then integrate its
ﬁndings into the theoretical literature of psychosis and sleep, in the pro-
cess highlighting priorities for future research.1.1. Psychotic experiences
This review is intended to cover the relationship between sleep dys-
function and the main positive psychotic experiences — hallucinations
and delusions. The empirical research indicates that non-affective psy-
chotic diagnoses such as schizophrenia actually containmultiple indepen-
dent experiences, including paranoia, grandiosity, and hallucinations
(Peralta & Cuesta, 1999; Ronald et al., 2014; Vazquez-Barquero, Lastra,
Nu, Castanedo, & Dunn, 1996; Wigman et al., 2011). Heritabilities of
each type of psychotic experience have been found to vary (Zavos et al.,
2014).
Whilst the individual psychotic experiences are typically studied in
psychotic disorders such as schizophrenia, they are also common in
the general population, with the prevalence of hallucinations and
delusions estimated from epidemiological studies to be in the region
of 7–11% (Linscott & van Os, 2013). In clinical groups, the association
of the individual psychotic experiences is inﬂated, due to Berkson's
bias, whereby individuals with multiple problems are more likely to
come into contact with clinical services (Bak, Drukker, van Os, &
Delespaul, 2005; Maric et al., 2004). The individual psychotic experi-
ences exist on spectra of severity in the general population; in other
words, like emotional disorders (Plomin, Haworth, & Davis, 2009),
they exist as quantitative traits in the general population, with clinical
populations experiencing the severe end of the continua. A focus on in-
dividual psychotic experiences has allowed development of detailed
theoretical models, for example for paranoia (Freeman, Garety,
Kuipers, Fowler, & Bebbington, 2002) accompanied by corresponding
innovations in treatment (Freeman & Garety, 2014).
The evidence is threefold supporting the idea that non-clinical and
clinical psychotic experiences exist on the same continuum: in both
groups they are associated with similar environmental (e.g. trauma,
cannabis use) and psychological factors (e.g. anomalous experiences,
worry) (Freeman, Pugh, Vorontsova, Antley, & Slater, 2010; Johns &
van Os, 2001); milder psychotic experiences are more common in fam-
ilies of individualswith psychotic disorders than familieswithout such a
history (e.g. van Os, Linscott, Myin-Germeys, Delespaul, & Krabbendam,
2009); and adolescents who report psychotic experiences are at greater
risk of developing psychotic disorders in adulthood (e.g. Fisher, Caspi, &
Poulton, 2013).
Therefore, in contrastwith existing reviews linking sleep and schizo-
phrenia (Benson, 2006, 2008; Cohrs, 2008; Lunsford-Avery & Mittal,
2013; Monti & Monti, 2004; Pritchett et al., 2012; Waters & Manoach,
2012; Zanini et al., 2013), this article will particularly focus on research
that investigates the association of sleep dysfunction with individual
psychotic experiences, with attention also paid to studies that jointly
assess delusions and hallucinations as positive symptoms. We will
Table 1b
Commonly assessed sleep variables.
Sleep or circadian
variable
Deﬁnition
Sleep latency Time from lights out until ﬁrst occurrence of sleep
Sleep Period Time
(SPT)
Time from sleep onset until ﬁnal awakening, including
intermittent waking periods
Total Sleep Time
(TST)
Total time spent in any REM or NREM sleep stage
Sleep efﬁciency Percentage of time in bed (TIB) spent asleep
REM onset latency Time between sleep onset and the ﬁrst occurrence of REM
REM density Measure of frequency of rapid eye movements during REM
sleep
Slow wave sleep Amount of non-REM sleep stages 3 and 4 (also known as
delta sleep)
Table 2
Sleep disorders and their symptoms.
Sleep disorder/
symptom
Deﬁnition/key symptoms Population
prevalence
(from DSM-V
APA, 2013)
Insomnia Difﬁculty initiating or maintaining sleep or
nonrestorative sleep causing signiﬁcant
functional impairment.
6–10%
Sleep apnoea A breathing related sleep disorder where
breathing is obstructed during sleep, blocking
2–4%
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ic experiences.
1.2. Sleep and sleep dysfunction
The regulation of sleep can be conceptualised in a two processmodel
(Borbély, 1982) comprising a circadian component (intrinsic synchroni-
sation of body functions to the light–dark cycle) and a homeostatic com-
ponent, commonly referred to as ‘sleep pressure’ or need for sleep,
which accumulates during wakefulness and is dissipated by sleep.
Sleep itself can be divided into rapid eye movement (REM) and non-
rapid eye movement (NREM) sleep stages. NREM sleep can further be
divided into stages 1, 2, 3 and 4 in order of increasingly deeper sleep.
Stages 3 and 4 are characterised by the presence of slow, high amplitude
waves of neural activity and are often referred to jointly as slow wave
sleep (SWS) or delta sleep. A typical sleep phase passes through
NREM stages 1 to 4 before moving to a REM sleep stage. This cycle
takes around 90min, and repeats throughout the night, with an increas-
ing predominance of REM sleep in the latter half of the night (Brown,
Basheer, McKenna, Strecker, & McCarley, 2012).
Using polysomnography (PSG — see Table 1a) these stages can be
identiﬁed, providing several objectivemeasures of sleep. Another objec-
tive measure of sleep can be gained from actigraphy. This technique re-
quires participants to wear a wrist watch style device which monitors
their movement and light exposure, usually over several weeks. This
can then allow interpolation of sleep–wake and circadian function
(when combined with melatonin sequencing). Key sleep parameters
relevant to this review are listed in Table 1b.
Sleep disorders comprise a broad range of disturbances (see
Table 2). All of these disorders are associated with a subjective com-
plaint of dissatisfaction in quality, timing, or amount of sleep, with
diagnosis requiring daytime distress and/or impairment. Deﬁnitive di-
agnosis of several sleep disorders (for example sleep apnoea) requires
polysomnographic assessment, although this is not time or cost-
efﬁcient to carry out on a large scale. Therefore,many studies investigat-
ing sleep dysfunction rely on self-report of dissatisfaction with sleep
quality, timing, or amount of sleep. Thesemeasuresmay then be consid-
ered as indexing symptoms of a sleep disorder such as insomnia (or
other sleep disorders with appropriate additional symptom reports,
e.g. nightmares) or be simply taken as a measure of lack of satisfaction
with sleep.
In this review, unless otherwise speciﬁed, sleep dysfunction will be
used as a broad term to encompass abnormalities in objective sleep var-
iables (Table 1b), sleep disorders or symptoms (Table 2), and also sub-
jective dissatisfaction with sleep in the absence of a sleep disorder
diagnosis.Table 1a
Objective sleep measurement methods.
Sleep or circadian
variable
Deﬁnition
Polysomnography
(PSG)
Recording of electrical activity during sleep from multiple
sources – typically including electroencephalography,
electrooculography, electromyography, and
electrocardiogram respectively monitoring electrical activity
in the brain, eyes, muscles and heart. May also include
respiratory indicators or other measurements.
Actigraphic
monitoring
Continuous activity monitoring, usually carried out over
several days via a device worn on the wrist, allows objective
measurement of sleep-wake patterns (time to sleep, time to
wake, sleep onset, night wakings etc.)
Melatonin
concentration
Melatonin production rises during evening and peaks during
the night. Irregular peaks or reduced amplitude in melatonin
cycles are associated with circadian rhythm sleep-wake
disorders (Table 2). Regular collection of saliva or urine allows
measurement of concentrations of melatonin throughout the
day, which can be combined with actigraphic monitoring to
assess circadian functioning1.3. Sleep dysfunction in schizophrenia
Schizophrenia is themost commonnon-affective psychotic disorder,
and a diagnosis long anecdotally linked with sleep dysfunction. There-
fore when reviewing the link between sleep dysfunction and psychotic
experiences, it is worthwhile to ﬁrst consider what has been learned
about the relationship between sleep dysfunction and schizophrenia.
However, there is a great deal of variability reported in the literature.
In part this can be explained by the heterogeneity of groups studied,
for example, in symptoms, age, medication status, and also by the
small sample sizes imposed by the demands of PSG. For example,
most of the sleep variables listed in Table1b have been reported to be al-
tered in patients with schizophrenia (Monti &Monti, 2004). Yet ameta-
analysis by Chouinard, Poulin, Stip, and Godbout (2004) found that
medication-free patients with schizophrenia only exhibited increased
sleep latency, decreased total sleep time, and decreased sleep efﬁciency.
Furthermore, treatment naïve patients were found to exhibit a different
set of sleep characteristics in comparison to the previously treatedoff airﬂow and disturbing sleep. The primary
symptoms are loud snoring and daytime
sleepiness.
Hypersomnia Characterised by symptoms of excessive
daytime sleepiness, and/or extended
nocturnal sleep period.
1%
Parasomnias A group of sleep disorders linked by abnormal
behaviours, emotions, and dreams during
sleep that lead to intermittent awakenings
and difﬁculty resuming sleep.
Varies across
disorder
Nightmare
disorder
A disorder within the parasomnia group,
characterised by frequent nightmares causing
clinically signiﬁcant distress or impairment in
functioning — one or more episodes a week is
classed as moderate severity.
6%
Circadian rhythm
sleep–wake
disorders
A group of sleep disorders resulting primarily
from alteration of the circadian system or to
misalignment between the endogenous
circadian rhythm and the sleep-wake
schedule required by an individual's
environment. These disorders are split into
types by the alteration seen for example —
delayed sleep phase, advanced sleep phase
and non-24 h sleep-wake type.
Varies across
sub-type
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with symptom and medication status. Various circadian rhythm alter-
ations such as melatonin phase and sleep/wake pattern irregularity
have also been widely reported among patients with schizophrenia,
and have previously been proposed to have etiological and therefore
therapeutic relevance to the disorder (Anderson & Maes, 2012; Monti
et al., 2013). Yet again, the interaction of circadian processes with anti-
psychotic medication and the wide range of dysfunction recorded pre-
vent more detailed conclusions. Overall, it is clear that many aspects
of sleep architecture are altered in individuals with schizophrenia, al-
though often the interpretation of a particular difference is challenging
due to the lack of consensus linking particular aspects of sleep architec-
ture (e.g. decreased stage 2 sleep) to daytime functioning (Wilson &
Argyropoulos, 2012).
Where data exist, they indicate that prevalence rates of sleep disor-
ders are elevated in schizophrenia. Themajority of research has focused
on insomnia, with estimates for the prevalence of clinically signiﬁcant
insomnia among individuals with a diagnosis of schizophrenia varying
from 36 to 80%, depending on study recruitment criteria and deﬁnition
of insomnia used (Freeman et al., 2009; Palmese et al., 2011; Xiang et al.,
2009). Regardless, even the lowest estimates support the conclusion
that rates of insomnia are elevated among patients with schizophrenia
as compared to the general population (see Table 2). Rates of sleep ap-
noea also appear elevated in individuals with schizophrenia — around
15% of patients have been found to exhibit clinically signiﬁcant symp-
toms (Sharafkhaneh, Giray, Richardson, Young, & Hirshkowitz, 2005).
The link between sleep apnoea and schizophrenia is likely to be partly
mediated by the increased BMI in patients with schizophrenia, which
is itself contributed to by long term use of antipsychotics and lifestyle
factors (Winkelman, 2001). However there is a possible direct contribu-
tion of particular antipsychotic medications via their effect on muscle
tone in the upper airway (Kalucy, Grunstein, Lambert, & Glozier,
2013). Symptoms of hypersomnia such as excessive daytime sleepiness
and extended nocturnal sleep period are also commonly observed in pa-
tients with schizophrenia, and are again likely to be partly inﬂuenced by
medication (Hawley, 2006; Hawley et al., 2010). For instance, one initial
empirical study suggested that daytime sleep propensity is lower in pa-
tientswith schizophrenia than in the non-clinical population, yet the re-
searchers also found that antipsychotic medication increased sleep
propensity and subjective complaints of sleepiness (Kluge et al.,
2012). No aggregated ﬁgure for parasomnia prevalence is available for
patients with schizophrenia, although there is recent evidence for an in-
creased rate of nightmares among individuals with psychotic disorders
(Michels et al., 2014; Sheaves, Onwumere, Keen, Stahl, & Kuipers, 2015).
Despite the apparent high prevalence of sleep disorders in patients
with schizophrenia, and improving sleep being among patients' highest
priorities for treatment (Auslander & Jeste, 2002; Waite et al., 2015),
sleep disorders in schizophrenia are rarely addressed directly. Clinicians
and researchers have traditionally described sleep difﬁculties in schizo-
phrenia as a secondary symptom, or simply ascribed their frequent pre-
sentation to the effects of antipsychotic medication or social isolation
(Wilson & Argyropoulos, 2012). Yet many sleep disorders have existing
effective treatments, which are beginning to be validated in psychiatric
groups (e.g. Freeman & Waite et al., 2015; Myers, Startup, & Freeman,
2011). This new approach coincides with the recent change in concep-
tualisation of sleep disorders in diagnostic manuals, with guidelines
now in place stating that clinically signiﬁcant sleep disorders should
be considered as a comorbid diagnosis and receive independent clinical
attention accordingly, regardless of the presence of other mental or
medical conditions (AASS, 2014; APA, 2013).1.4. The current review
This review will restrict itself to examining the association between
sleep dysfunction and individual psychotic experiences, speciﬁcallyfocusing on delusions and hallucinations, across clinical and non-
clinical populations. We sought to address the following questions:
1. Do sleep dysfunction and psychotic experiences co-occur?
2. Does sleep dysfunction predict onset or persistence of individual psy-
chotic experiences? (or vice versa)
3. Does a change in sleep inﬂuence psychotic experiences? (or vice versa)
In the course of this investigationwewill also seek to identify factors
found to mediate the relationship between sleep and psychotic
experiences.
2. Method
A search was carried out on PubMed for English language papers
published in peer-reviewed journals containing the following terms:
(Sleep OR Insomnia OR Dream* OR Nightmare*) AND (Delus* OR
Hallucinat* OR Psychosis OR Psychotic OR Schizophren*), published
from 1980 until the present day.
2.1. Inclusion criteria
Papers were required to have reported all of the below:
1. Explicit measures of psychotic experiences or positive symptoms;
2. Objective or subjective measure of sleep dysfunction;
3. Analysis testing a relationship between these two factors.
2.2. Exclusion criteria
Papers fulﬁlling any of the below criteria were excluded:
1. Single case studies
2. Relating primarily to:
a. Dementias or other neurological conditions
b. Bipolar disorder or other affective psychoses (including post-
partum psychosis)
c. Schizotypy or dissociation
d. Hypnogogic or hypnopompic hallucinations
e. Narcolepsy
This search revealed 2657 papers (July 2015). Titles and abstracts
were scanned, and if appropriate the whole paper, in order to ascertain
whether each item fulﬁlled the inclusion and exclusion criteria. The ref-
erence lists of relevant papers were also scanned for further citations.
Three papers from within the research group which at the time of the
search were currently in revision or in press prior to publication were
also included. This yielded a total of 66 papers, which for the purposes
of discussion have been divided into investigations on non-clinical and
clinical groups. See Fig. 1 for a PRISMA ﬂow diagram of the systematic
review process.
3. Results
3.1. General population
Eighteen papers investigating the relationship between sleep dys-
function and psychotic experiences in the general population were
found (see Table 3). The majority of studies utilise subjective reports
of either insomnia symptoms (8 papers) or other sleep disturbances
such as nightmares (7 papers), while the remaining three papers focus
on sleep deprivation.
3.1.1. Insomnia and psychotic experiences
Of the individual psychotic experiences, the relationship between
paranoia and insomnia has received themost attention in the literature.
Evidence from multiple sources suggests that insomnia and paranoia
Fig. 1. PRISMA Cohort Diagram.
100 S. Reeve et al. / Clinical Psychology Review 42 (2015) 96–115co-occur. For example, in national epidemiological surveys, a diagnosis
of insomnia was associated with odds ratios (OR) of 1.78–2.54 for
reporting concomitant paranoia (Freeman et al., 2011), with chronic in-
somnia linked to a 5 times increased likelihood of endorsing the state-
ment ‘a group of people are plotting to cause you serious harm or
injury’ (Freeman, Brugha, et al., 2010). This relationship was partially
mediated by depression and anxiety symptoms, and to a more limited
extent by cannabis use, although an independent contribution of insom-
nia symptoms to paranoia remained even after controlling for these fac-
tors (Freeman et al., 2009, 2011).
In addition to the co-occurrence of insomnia with paranoia, longitu-
dinal evidence indicates that insomnia predicts future paranoia. Insom-
nia was found to predict new paranoid thinking (OR 1.49–1.84) and
persistence of existing paranoid thinking (OR=1.2) at an18month fol-
low up of an epidemiological population survey (Freeman et al., 2012).
In a smaller study, still using dimensional measures of insomnia and
paranoia, insomnia was a signiﬁcant predictor of paranoia and PTSD
symptoms over 6 months (Freeman et al., 2013).
Insomnia has also been found to co-occur with and predict new hal-
lucinatory experiences in the same general population samples (whilst
controlling for both affective symptoms and paranoia) (Sheaves et al.,
submitted). A cross sectional analysis found that insomnia symptoms
were associatedwith a two to four times increased likelihood of endors-
ing hallucination items relating to hearing or seeing things that others
couldn't, or hearing voices saying words or sentences. Longitudinal
analysis further revealed that insomnia symptoms as baseline predicted
new hallucinatory experiences at 18 month follow up.
More broadly, a largeWHO study combining data from 56 countries
(n = 267,692) corroborates a cross-sectional relationship between
sleep problems (indexed by a single self-report questionnaire itembased on insomnia criteria) and several psychotic experiences. Self-
reported sleep disruption signiﬁcantly increased the likelihood of con-
comitant psychotic experiences (OR = 2.26–2.84 across different psy-
chotic experiences), even after controlling for anxiety and depression
(remaining ORs of 1.54–1.68) (Koyanagi & Stickley, 2015).
A recent cross-sectional study examined the genetic and environ-
mental inﬂuences on sleep dysfunction and six individual psychotic ex-
periences (Taylor, Gregory, Freeman, & Ronald, 2015). Five thousand
16-year old twin pairs completed self-report assessments for insomnia
symptoms, subjective sleep quality, paranoia, hallucinations, cognitive
disorganisation, grandiosity, anhedonia, and (parent rated) negative
symptoms. The latter three factors were found to only havemild covari-
ance with the sleep measures, but paranoia, hallucinations and cogni-
tive disorganisation all demonstrated a strong association with the
sleep dysfunction variables. Further analysis utilising modelling of ge-
netic, environmental, and non-shared environment inﬂuences on the
sleep and psychotic experience phenotypes demonstrated an
aetiological overlap (i.e. shared genetic and environmental mecha-
nisms). These relationships reduced, but again remained signiﬁcant,
after controlling for negative affect. Overall there is strong evidence
for insomnia co-occurring with a range of psychotic experiences, and
some indications of insomnia predicting later psychotic experiences
(limited to paranoia and hallucinations at this point). It should be
noted that none of these longitudinal studies had the statistical power
to test the reverse association (i.e. psychotic experiences predicting
later sleep dysfunction). Furthermore, no studies have attempted to re-
duce insomnia in a non-clinical population to test the effect on
psychotic-like experiences. In terms of mediating factors for the rela-
tionship between insomnia and psychotic experiences, there is evi-
dence of partial mediation by depression and anxiety.
Table 3
Studies addressing the link between sleep and psychotic experiences in non-clinical populations.
Citation Design N Sample characteristics Psychosis measure(s) Sleep dysfunction
measure(s)
Comment on ﬁndings Linked?
(Fisher et al.
(2014)
Longitudinal 6796 Children (aged 12) from
population cohort
(ALSPAC)
Psychotic experiences
PLIKSi
Sleep disorder symptoms
Postal questionnaires
(completed by mothers) at
age 2.5, 3.5, 4.75, 6.75, and
9 years.
Sleep problems at 12 years
assessed in semi-structured
diagnostic-based interview
with child.
Children with more frequent
nightmares between 2.5 and
9 years more likely to report
psychotic experiences at age 12.
Children reporting any
parasomnia at age 12 also found
to have higher rates of psychotic
experiences.
Y
Freeman et al.
(2009)
Cross-sectional 300 Convenience sample
from community
Paranoia
G-PTS
Insomnia symptoms
ISI, Sleep-50
Insomnia associated with
paranoid thinking, association
partly accounted for by anxiety
and depression.
Y
Freeman, Brugha,
et al. (2010)
Cross-sectional 8580 National epidemiological
survey (British National
Survey of Psychiatric
Morbidity)
Paranoia
PSQ, SCID-II
Insomnia symptoms
CIS-R
Insomnia associated with an
increase in paranoid thinking,
association partly accounted for
by affective symptoms or
cannabis use.
Y
Freeman et al.
(2011)
Cross-sectional 7281 National epidemiological
survey
(USA — Adult Psychiatric
Morbidity Survey)
Paranoia
Paranoia items from
survey (3)
Insomnia symptoms
CIS-R
Paranoia associated with
insomnia, odds ratios of
insomnia diagnosis increases
with level of paranoia.
Y
Freeman et al.
(2012)
Longitudinal 2382 National epidemiological
survey (British
Psychiatric Morbidity
Survey 2000)
Paranoia
PSQ (3 items)
SCID-II (at baseline and
18 month follow up)
Insomnia symptoms
CIS-R (at baseline and
18 month follow up)
Insomnia symptoms predicted
new paranoid thinking or
persistence of existing paranoid
thinking at 18 month follow-up.
Y
Freeman et al.
(2013)
Longitudinal 106 Individuals attending
hospital after an assault
Paranoia
G-PTS
SSPS
PANSS
PSYRATS
4 paranoia and threat
related visual analogue
scales
(all at baseline and 6
month follow up)
Insomnia symptoms
ISI (at baseline and 6 month
follow up)
Insomnia at baseline was found
to predict paranoia (G-PTS) and
post-traumatic stress disorder
symptoms at 6 month follow up.
Current insomnia was also a
signiﬁcant predictor of paranoia
scores at 6 months.
Y
Hurdiel et al.
(2014)
Manipulation
(sleep
deprivation)
17 Volunteers completing
ultramarathon event
Psychotic experiences
Hallucinations — open
ended question on
completion
Objective sleep
Wrist watch actigraphy
throughout event
Sleep deprivation
Average 46 h 38 min
4 out of 17 participants reported
experiencing hallucinations
during the exercise event.
Y
Jeppesen et al.
(2014)
Cross-sectional 1623 Adolescents (aged 11/12
years) from population
cohort
Psychotic experiences:
K-SADS-PL
Subjective sleep
Self-report of sleep
disturbance in structured
interview
Likelihood of psychotic
experiences increased with
sleep problems and emotional
or neurodevelopmental
disorders.
Increased prevalence of sleep
disorders among children with
psychotic experiences.
Y
Kahn-Greene
et al. (2007)
Manipulation
(sleep
deprivation)
25 Non-clinical volunteers
(recruited from military)
Psychotic experiences
PAI (pre and post sleep
deprivation)
Sleep deprivation
56 h
Sleep deprivation resulted in
increase in anxiety, depression
and paranoia, but not
manic-related symptoms or
schizophrenia symptom factors.
Y
Koyanagi and
Stickley (2015)
Cross-sectional 267,692 WHO population based
survey (56 countries)
Psychotic experiences
Single items from CIDE
for delusional mood,
delusions of
persecution/reference,
delusions of control,
hallucinations
Insomnia symptoms
1 item for presence of
insomnia symptoms
(5 point scale of ‘none’ to
‘extreme’)
Sleep problems associated in
dose–response fashion with
psychotic symptoms in almost
all countries with signiﬁcant
ORs from 2.26–2.84 (1.54–1.68
after controlling for anxiety and
depression).
Y
Lee et al. (2012) Cross-sectional 7172 23 high school cohorts of
students (aged 12–17)
Psychotic- experiences
ESI
Psychosis risk:
Y-PARQ
Insomnia
Self report questionnaire
modelled on ICD-10
diagnostic criteria for
insomnia
Excessive Daytime Sleepiness
ESS
Cataplexy
Single item, muscle
weakness
Snoring
Single item, frequency of
Insomnia and excessive daytime
sleepiness predicted psychotic
like experiences (and higher
risk scores for psychosis) in
adolescent group, independent
of depressive symptoms.
Y
(continued on next page)
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Table 3 (continued)
Citation Design N Sample characteristics Psychosis measure(s) Sleep dysfunction
measure(s)
Comment on ﬁndings Linked?
snoring
Levin and
Fireman (2002)
Cross-sectional 116 Undergraduate
psychology students
selected for high
nightmare prevalence (at
least 3–10 a year) from
screening survey
Psychoticism/paranoia
SCL-90-R
Nightmares
Dream log
Nightmare distress (not
frequency) associated with
paranoia, anxiety, depression.
Nightmare frequency associated
with psychoticism scale score.
Y
Oshima et al.
(2010)
Cross-sectional a) 279
b) 62
High school cohort of
students (aged 12–17)
a) singletons
b) twin students
(31 pairs)
Psychotic- experiences
Custom self-report
questionnaire (4 items)
Subjective sleep
GHQ-12
Poor sleep associated with
psychotic like experiences.
Y
Petrovsky et al.
(2014)
Manipulation
(sleep
deprivation)
24 Student volunteers Psychotic- experiences
PSI (pre and post sleep
deprivation)
Sleep deprivation
Overnight sleep deprivation
Sleepiness
SSS at 9 pm and from 7 to
10 am following morning
(6 time points in total)
Sleep deprivation induced
perceptual distortions, cognitive
disorganisation and anhedonia,
but not mania, paranoia or
delusional thinking.
Y
(Sheaves,
Bebbington,
et al.,
submitted)
Longitudinal a) 8580
b) 7403
c) 2046
National epidemiological
surveys:
a) British Psychiatric
Morbidity Survey
2000
b) British Psychiatric
Morbidity Survey
2007
c) British Psychiatric
Morbidity Survey
2000 18 month
follow up
Paranoia and
hallucinations
PSQ (2 items) (at
baseline and 18 month
follow up)
Insomnia symptoms
CIS-R (at baseline and
18 month follow up)
Insomnia predicted new
hallucinatory experiences at
18 month follow up.
Presence of insomnia raised
likelihood of reporting
hallucinations cross-sectionally.
All remained signiﬁcant when
controlling for depression,
anxiety and paranoia.
Y
Taylor et al.
(2015)
Cross-sectional a) 5076
b) 5059
a) Twin pairs (aged 16)
from population co-
hort
b) parents of twins
Psychotic- experiences
SPEQ
Subjective sleep
PSQI
Insomnia symptoms
ISI
Shared genetic and
environmental mechanisms for
psychotic experiences and sleep
disturbances – association
reduced but remained
signiﬁcant after controlling for
negative affect.
Y
Thompson et al.
(2015)
Longitudinal 4270 18 year old population
cohort sample (ALSPAC)
Psychotic- experiences
PLIKSi (at age 12 and
18)
Sleep disorder symptoms
Postal questionnaires
(completed by mothers) at
age 2.5, 3.5, 4.75, 6.75, and
9 years.
Sleep problems at 12 years
assessed in semi-structured
diagnostic-based interview
with child.
Nightmares at age 12 a
signiﬁcant predictor of
psychotic experiences at age 18,
remaining after adjustment for
mood and other confounders.
Y
CIDI = (Kessler & Ustün, 2004); CIS-R = Clinical Interview Schedule (revised) (Lewis, Pelosi, Araya, & Dunn, 1992); ESI = Eppendorf Schizophrenia Inventory (Mass, 2000); ESS =
Epworth Sleepiness Scale (Johns, 1991); GHQ-12 = 12 item version of the General Health Questionnaire (Goldberg & Williams, 1988); G-PTS = Green et al. paranoid thoughts scale
(Green et al., 2008); ISI = Insomnia Severity Index (Morin, 1993); K-SADS-PL- Schedule for schizophrenia and affective disorders for school-age children, present and lifetime edition
(Kaufman et al., 1997); PAI = Personality Assessment Inventory (Morey, 1991); PANSS= Positive and Negative Symptom Scale (Kay et al., 1987); PLIKSi = Psychosis-Like Symptom In-
terview (Horwood et al., 2008); PSI= Psychotomimetic States Inventory (Mason et al., 2008); PSQ=Psychosis Screening Questionnaire (Bebbington &Nayani, 1995); PSQI= Pittsburgh
SleepQuality Index (Buysse, Reynolds,Monk, Berman,& Kupfer, 1989); PSYRATS=Psychotic symptomrating scales (Haddock,McCarron, Tarrier, & Faragher, 1999); SCID-II= Structured
Clinical Interview for DSM-IV disorder (First, Gibbon, Spitzer, Williams, & Benjamin, 1997); SCL-90-R = Symptom Checklist 90 (Revised) (Derogatis, 1994); SLEEP-50 = (Spoormaker,
Verbeek, van den Bout, & Klip, 2005); SPEQ = Speciﬁc Psychotic Experiences Questionnaire (Ronald et al., 2014); SSPS = State Social Paranoia Scale (Freeman et al., 2007); SSS =
Stanford Sleepiness Scale (Hoddes, Zarcone, Smythe, Phillips, & Dement, 1973); Y-PARQ = Youth Psychosis at Risk Questionnaire (Ord, Myles-Worsley, Blailes, & Ngiralmau, 2004).
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A co-occurrence between psychotic experiences and sleep disorders
other than insomnia is also supported by the literature. A number of
sleep disorder symptoms (including excessive daytime sleepiness, cata-
plexy, and excessive snoring)were found to predict psychotic like expe-
riences in adolescent samples (Lee, Cho, Cho, Jang, & Kim, 2012; Oshima
et al., 2010). In the former study this relationship reduced but remained
signiﬁcant after controlling for depressive symptoms.
The likelihood of reporting psychotic experiences in another young
sample (aged 11–12) increased with the number of reported sleep
problems, including nightmares and daytime fatigue (Jeppesen et al.,
2014). Distress associated with nightmares in a student sample wasassociated with increased paranoia, anxiety, and depression (as
well as poorer occupational functioning) (Levin & Fireman, 2002).
Findings from the ALSPAC longitudinal cohort have also indicated that
parasomnias during childhood (nightmares and night terrors) predict
psychotic experiences at age 12 (Fisher et al., 2014), and that
nightmares at age 12 predict psychotic experiences at 18 (Thompson
et al., 2015) even after adjusting for mood and psychotic experiences
at age 12.
Altogether, these studies suggest that the relationship between
sleep dysfunction and psychotic experiences is not limited to insomnia,
but extends to other sleep disorders, and that these disorders co-occur
with and may predict psychotic experiences. However, these ﬁndings
103S. Reeve et al. / Clinical Psychology Review 42 (2015) 96–115are primarily based upon adolescent samples, and there is evidence that
some sleep disorders may be more common in this group than in the
adult population (e.g. parasomnias: Laberge, Tremblay, Vitaro, &
Montplaisir, 2000). Therefore further investigation is needed to explore
whether these links between parasomnias and excessive daytime sleep-
iness and psychotic experiences are also present in the adult population.
3.1.3. Sleep deprivation
Three studies havemanipulated sleep via sleep deprivation to inves-
tigate its impact on psychotic-like experiences.
Kahn-Greene, Killgore, Kamimori, Balkin, and Killgore (2007) de-
prived 25 non-clinical volunteers of sleep for 56 h, administering the
Personality Assessment Inventory (PAI; Morey, 1991) at baseline and
after sleep deprivation. Following sleep deprivation, increases were ob-
served in the anxiety, depression and paranoia factors, but not in ‘manic
related symptoms’ or ‘schizophrenia symptoms’ factors of the PAI. Yet
with the exception of paranoia the scale dimensions do not appear to
differentiate positive psychotic experiences from negative symptoms
or affective symptoms, therefore it is difﬁcult to interpret these results
with regard to particular psychotic experiences.
In the second sleep deprivation study a student sample underwent a
night of sleep deprivation or normal sleep in two counterbalanced ses-
sions under laboratory conditions (Petrovsky et al., 2014). The psy-
chotomimetic states inventory (PSI; Mason, Morgan, Stefanovic, &
Curran, 2008) – a scale previously utilised for self-report of the effects
of cannabis and ketamine on non-clinical volunteers in research con-
texts – was administered in the evening and morning for both condi-
tions. This experiment found that the sleep deprivation condition
resulted in signiﬁcantly higher ratings in several PSI subscales (percep-
tual distortions, cognitive disorganisation, and anhedonia) but not
others (mania, paranoia or delusional thinking). No data on mood
changes were collected. Given the robust link between insomnia and
paranoia discussed previously (Freeman, Brugha, et al., 2010; Freeman
et al., 2009, 2011, 2012), it is intriguing that no effects of sleep depriva-
tion on paranoia were reported in this study. One potential rationale
could be that the 8 item PSI subscale for paranoia includes several
items which are less speciﬁc to persecutory ideation (e.g. “you feel
that you deserve to be punished”, “you feel that no-one understands
you”) than the questionnaire items used in the paranoia-focused studies
e.g. the Green et al. Paranoid Thoughts Scale (Green et al., 2008).
The last sleep deprivation study identiﬁed by the review took a
somewhat different approach in utilising natural conditions of sleep
deprivation— in this case by competitors taking part in a 168 km ultra-
marathon event (Hurdiel et al., 2014). Wrist actigraphy was used to
track volunteer competitors in this event (involving an average of
46 h 38 min of wakefulness for this group), and on completion of the
event a short questionnaire was ﬁlled out including an open-ended
item asking about experiences of sleep deprivation (including halluci-
nations). Four of the seventeen volunteers reported experiencing hallu-
cinations during the event.
These studies do indicate that experimentally reducing sleep in-
creases psychotic-like experiences, although the evidence is inconsis-
tent with regard to particular psychotic experiences. Besides the issues
already highlighted in the questionnaires employed, other limitations
are that all of the above studies have used small samples, and none in-
cludes analyses for mediating factors. In the case of the last study,
there was also no baseline measurement or control group.
3.2. Clinical populations
Tables 4–8 contain the forty-nine clinical studies retrieved by the
search terms. Research in these clinical groups is complicated by the
heterogeneity of individuals with psychosis, such as differing medica-
tion status, age, and current symptom presentation.
Furthermore, many of the studies in clinical populations poorly differ-
entiate between individual psychotic experiences, both in recruitmentand in the measures used. Over three quarters of studies retrieved were
carried out with a group recruited for a diagnosis of schizophrenia or an-
other psychotic disorder (41 papers), regardless of symptom presenta-
tion. Other participants were recruited based on broadly deﬁned
psychotic symptoms (5 papers). Another four studies utilise differing
criteria (based on a mixture of positive psychotic and other symptoms)
for selecting a sample at high risk of psychosis. Only 3 studies have ad-
dressed individual psychotic experiences in relation to sleep, and these
predominantly focus on paranoia and persecutory delusions.
3.2.1. Polysomnography
Polysomnographicmethods have beenwidely applied in this clinical
population (Table 4). All of the studies are cross-sectional designs, using
small samples, often seeking to associate clinical severity or symptom
proﬁles with particular differences in sleep architecture.
Themost consistently reported ﬁndings related to positive psychotic
symptoms are REM sleep alterations. Positive symptoms have been
found to be associatedwith a lowered REM onset latency in unmedicat-
ed and medication naive patients (Lauer, Schreiber, Pollmächer,
Holsboer, & Krieg, 1997; Poulin, Daoust, Forest, Stip, & Godbout, 2003;
Tandon et al., 1992; Yang & Winkelman, 2006) although there are in-
consistent results, mostly from studies with smaller sample sizes
(Ganguli, 1987; Tandon, Shipley, Eiser, & Greden, 1989; Taylor,
Tandon, Shipley, Eiser, & Goodson, 1991). Similarly, reduced REM
onset latency and an increased percentage of time in REM sleep were
correlated with positive symptom severity (Sarkar, Katshu, Nizamie, &
Praharaj, 2010). Another sleep EEG study found that positive symptom
scores partially explained the variation (63%) in high frequency EEG ac-
tivity during REM sleep (Tekell et al., 2005). An association between in-
creased positive psychotic symptoms and reduced REMdensity has also
been reported (Rotenberg et al., 1997; Yang & Winkelman, 2006).
The interpretation of these REM sleep abnormalities is opaque, as
the function of REM sleep and the impacts of alterations to it are still
the subject of debate (e.g. Wamsley, 2014). Regardless, these changes
do at the very least point to a disruption in neural regulation of sleep
in individuals with psychosis, which could have an impact throughout
the sleep period. For example, a reduced REM sleep onset latency may
mean that less time is spent in slowwave sleep prior to ﬁrst REM epoch.
In contrast to REM sleep, alterations in slow wave sleep have been
more traditionally associated with negative symptoms e.g. (Kajimura
et al., 1996; Keshavan et al., 1995, 1998). Yet three recent polysomno-
graphic studies have reported that a reduced number and amplitude
of spindles recorded during slow wave sleep is associated with greater
positive symptom severity (Ferrarelli et al., 2010; Sarkar et al., 2010;
Wamsley et al., 2012) — although in one case a reverse association
(increased sleep spindle amplitude with increased positive symptom
score) was reported (Manoach et al., 2014).
However, as all of these polysomnographic studies are cross-
sectional they are unable to provide any conclusions as to whether the
REM sleep changes occur prior to psychosis or predict other clinical var-
iables in the longer term. Furthermore, in all of these studies clinical par-
ticipants were not recruited on the basis of particular psychotic
experiences, and themeasures used amalgamatemultiple psychotic ex-
periences, meaning that it is not possible to speculate on whether par-
ticular psychotic experiences have differing associations with the
sleep architecture changes described.
3.2.2. Actigraphy and circadian rhythm
Several recent studies have used actigraphy to assess sleep wake
patterns and circadian dysfunction in psychosis, with the aim of linking
circadian proﬁles to clinical features (Table 5).
One longitudinal study has indicated that sleep–wake abnormalities
detected by actigraphy predict psychotic symptoms at one year follow
up in a high risk youth sample (Lunsford-Avery, LeBourgeois, Gupta, &
Mittal, 2015). Another smaller longitudinal study (clinical group n =
6) found that daily variations in sleep duration were associated with
Table 4
Studies addressing the link between positive symptoms and sleep measured with polysomnography in clinical groups.
Citation N Sample characteristics Psychosis
measure(s)
# PSG
nights
Comment on ﬁndings Linked?
Benson and Zarcone
(1993)
a) 21
b) 24
c) 13
a) Patients with schizophrenia (at least 2 weeks
medication free)
b) Patients with major depressive disorder
c) Non-clinical controls
Positive symptoms
BPRS
2 No signiﬁcant differences in REM eye movements
across groups, one positive correlation for a
hallucinatory behaviour item and REM density in
the schizophrenia group.
Y
(partly)
Ferrarelli et al. (2010) a) 49
b) 20
c) 44
a) Patients with schizophrenia
b) Patients with other diagnoses receiving
antipsychotic medication
c) Non-clinical controls
Positive symptoms
PANSS
1 Negative correlation between sleep spindle
activity and number and positive symptoms.
Y
Ganguli (1987) a) 8
b) 8
c) 16
d) 16
e) 10
a) Patients with delusional depression
b) Depression
c) Non-clinical controls
Positive symptoms
BPRS
2 Positive correlation between REM latency and
severity of psychosis, but trend failed to reach
statistical signiﬁcance.
Y
(partly)
Kajimura et al. (1996) a) 6
b) 6
a) Patients with schizophrenia (outpatients)
b) Non-clinical controls
Positive symptoms
BPRS
1 Negative correlation between slow wave sleep
and negative symptom scale.
No associations reported between PSG variables
and positive symptoms.
N
Keshavan et al. (1995) a) 24
b) 5
c) 4
d) 5
Patients with:
a) Schizophrenia
b) Schizoaffective bipolar
c) Schizoaffective depressed
d) Delusional disorder
Positive symptoms
BPRS
SAPS
2 or 3 Negative correlation between slow wave sleep
and negative symptom scale.
No association reported between SWS and
positive symptoms.
N
Keshavan et al. (1998) a) 30
b) 30
c) Unmedicated patients with schizophrenia
(medication naïve or medication free for
average of 40 weeks)
d) Non-clinical age and sex matched controls
Positive symptoms
BPRS
2 or 3 Patients with schizophrenia had reduced slow
wave sleep.
No correlations between positive symptoms and
slow wave sleep.
N
Lauer et al. (1997) a) 22
b) 20
a) Drug naïve, ﬁrst episode or acute exacerbation
patients with schizophrenia
b) Non-clinical age and sex matched controls
Positive symptoms
BPRS
1 Positive symptoms scores correlate negatively
with REM onset latency, but reported to be driven
by conceptual disorganisation factor rather than
all positive symptom factors.
Y
Manoach et al. (2014) a) 26
b) 25
c) 19
d) 23
a) Patients with schizophrenia (inpatient and
outpatient, n = 11 early course)
b) Non-clinical age and sex matched controls (to
patient group)
c) First degree relatives of patients with
schizophrenia
d) Non-clinical age, sex and education matched
controls (to relatives group)
Positive symptoms
SAPS
1 Positive correlation increased amplitude of
spindles during stage 2 sleep and positive
symptoms (only found in patients with
schizophrenia).
Y
Poulin et al. (2003) a) 11
b) 11
a) Patients with ﬁrst episode psychosis
(medication naïve)
b) Non-clinical controls
Positive symptoms
BPRS
1 or 2 Positive symptom scores correlated negatively
with REM onset latency.
Other sleep measures correlate with total
symptom severity.
Y
Rotenberg et al. (1997) 20 Patients with schizophrenia (medicated) Positive symptoms
PANSS
3 Positive symptoms correlated with lowered REM
density.
Y
Sarkar et al. (2010) a) 20
b) 14
c) 20
a) Patients with schizophrenia
b) First degree relatives of patients
c) Non-clinical age and sex matched controls
Positive symptoms
BPRS
PANSS
1 Positive symptoms correlated positively with
percentage of time in REM sleep, and negatively
correlated with REM sleep onset latency.
Y
Tandon et al. (1989) 10 Patients with schizophrenia (inpatients) Positive symptoms
BPRS
1 No difference in BPRS score between patients
with and without REM abnormalities.
N
Tandon et al. (1992) a) 20
b) 20
c) 15
a) Drug-naïve schizophrenia patients
b) Previously medicated but drug free schizo-
phrenia patients
c) Non-clinical controls
Positive symptoms
BPRS
1 Positive symptoms scores correlate negatively with
REM onset latency, but effect only found in
previously treated group, not in the drug naïve
group.
Y
(partly)
Taylor, Tandon, Shipley,
Eiser, et al. (1991)
36 Patients with schizophrenia (inpatients) Positive symptoms
BPRS
1 No difference in BPRS positive scale score in
patients with REM at sleep onset (n = 6) versus
patients without REM at sleep onset (n = 30).
N
Tekell et al. (2005) a) 17
b) 15
c) 17
a) Patients with schizophrenia
b) Patients with major depression
c) Non-clinical controls
Positive symptoms
BPRS
SAPS
1 Positive symptom scores explained signiﬁcant
amount of variance in high frequency EEG activity
during REM sleep.
Y
Tesler et al. (2015) a) 9
b) 15
a) Adolescents (aged 14–18) meeting criteria for
early onset schizophrenia spectrum disorder
b) Non-clinical age and sex matched controls
Positive symptoms
PANSS
1 Reduced sleep spindle density in clinical group
correlated with positive symptom severity.
Y
Wamsley et al. (2012) a) 21
b) b)
17
a) Chronically medicated patients with
schizophrenia
b) Non-clinical age and sex matched controls
Positive symptoms
PANSS
1 Reduced amplitude and power of individual
spindles correlated with greater severity of
positive symptoms.
Y
Yang and Winkelman,
(2006)
a) 15
b) 15
a) Inpatients with schizophrenia (at least
2 weeks drug free)
b) Non-clinical controls
Positive symptoms
BPRS
1 Positive symptoms correlated with lowered REM
density.
Y
BPRS = Brief Psychiatric Rating Scale (Overall & Gorham, 1962); SAPS = Scale for Assessment of Positive Symptoms (Andreasen, 1984); PANSS = Positive and Negative Symptom Scale
(Kay et al., 1987).
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Table 5
Studies addressing the link between positive psychotic symptoms and sleep measured with actigraphy in clinical groups.
Citation Design N Sample characteristics Psychosis measure(s) Sleep dysfunction
measure(s)
Comment on ﬁndings Linked?
Afonso, Brissos,
et al. (2011)
Cross sectional 23 Patients with schizophrenia
(outpatients)
Positive symptoms
PANSS (used to divide into
predominant positive
(n = 11) and predominant
negative (n = 12) groups)
Subjective sleep
PSQI
Circadian sleep measures
Wrist actigraphy (7 days
continuous)
Patients with more positive
symptoms report reduced sleep
quality and quality of life in
comparison to patients with
predominantly negative
symptoms.
Y
Afonso et al.
(2014)
Cross sectional a) 34
b) 24
a) Patients with schizophrenia
(outpatients)
b) Age and gender matched
non-clinical controls
Positive symptoms
PANSS
Subjective sleep
PSQI
Circadian sleep measures
Wrist actigraphy
Increased positive symptoms
associated with reduced sleep
quality and more disturbed
sleep-wake patterns in patient
group.
Y
Bromundt
et al. (2011)
Cross-sectional 14 Patients with schizophrenia
(outpatients)
Positive symptoms
PANSS
Subjective sleep
PSQI
Circadian sleep measures
Wrist actigraphy
(21 days)
Melatonin proﬁling
(48 h window collected
weekly)
No relationship found between
positive symptoms and
cognitive performance or
sleep-wake measures.
N
Lunsford-Avery
et al. (2015)
Longitudinal a) 36
b) 31
a) Ultra high risk youth
b) Non-clinical controls
Psychotic symptoms
SIPS
SCID
(both at baseline and
12 month follow up)
Circadian sleep measures
Wrist actigraphy
Subjective sleep
PSQI
Sleep disturbance signiﬁcantly
associated with increased
positive symptoms at baseline
in high risk group, and predict
clinical symptoms at 12
months when controlling for
age, depression and baseline
psychotic symptoms.
Y
Martin et al.
(2001)
Cross-sectional 28 Older patients with
schizophrenia
(mean age = 58 yrs)
Positive symptoms
BPRS
SAPS
Objective sleep
Wrist actigraphy
(activity and light
exposure – 3 days)
No clinical or demographic
variables were related to sleep
wake characteristics.
N
Waters et al.
(2011)
Longitudinal a) 6
b) 7
a) Patients with schizophrenia
(outpatients)
b) Age and gender matched
non-clinical controls
Positive symptoms
BPRS
Psychotic experiences
12 item questionnaire
including 8 items on
psychotic experiences,
4 on mood (daily)
Subjective sleep
PSQI
Circadian measures
Wrist actigraphy (up to
28 days)
Sleep variations in the clinical
group predicted daily changes
in positive symptoms and
negative mood.
Y
Wichniak et al.
(2011)
Cross-sectional 73 Patients with schizophrenia
spectrum disorder (treated
with olanzapine or risperidone)
Positive symptoms
PANSS
Objective sleep
Wrist actigraphy (7 days)
Positive symptom severity
correlated with reduced
activity.
Y
Wulff et al.
(2012)
Cross sectional a) 20
b) 21
a) Patients with schizophrenia
(outpatients)
b) Age, gender and employ-
ment matched non-clinical
controls
Positive symptoms
Clinician scored presence
or absence of positive
symptoms
Subjective sleep
PSQI
Circadian measures
Wrist actigraphy
Melatonin proﬁling
(48 h window collected
weekly)
Presence or absence of positive
symptoms did not predict
differences in circadian
sleep/wake disruptions.
N
BPRS = Brief Psychiatric Rating Scale (Overall & Gorham, 1962); PANSS= Positive and Negative Symptom Scale (Kay et al., 1987); PSQI = Pittsburgh Sleep Quality Index (Buysse et al.,
1989); SCID = Structured Clinical Interview for DSM-IV Disorder (First et al., 1997); SIPS = Structured Interview for Prodromal Symptoms (Miller et al., 1999).
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with schizophrenia (Waters et al., 2011). Furthermore, the changes in
mood for the clinical group partly explained the association between
sleep and positive symptom scores. A cross sectional study with a
large sample of outpatients with schizophrenia (n=75) identiﬁed a re-
lationship between reduced activity and positive symptom severity
(Wichniak et al., 2011). On the other hand, two other cross-sectional
studies utilising melatonin proﬁling as well as actigraphy (Bromundt
et al., 2011; Wulff, Dijk, Middleton, Foster, & Joyce, 2012) did not ﬁnd
any signiﬁcant association between positive symptom scores and
sleep–wake or circadian phase abnormalities. Another report from an
actigraphic monitoring study on older patients with schizophrenia
found no associations between any clinical variables (including positive
symptoms) and activity levels (Martin et al., 2001).
From these initial ﬁndings, it seems likely that circadian dysfunction
plays a part in the observed sleep disruption in individuals with psycho-
sis. However, further studies utilising circadian proﬁling to link particu-
lar characteristics (e.g. advanced phase, delayed phase, free running)with symptomatology are a clear next step. The high diversity of sleep
and circadian phenotypes reported in these initial small samples indi-
cates that much larger studies will be required to identify if there are
any particular associations by psychotic experience type.
3.2.3. Sleep and clinical course of psychosis
Several different types of study have linked sleep with the clinical
course of psychosis, including investigations of individuals at risk of
transition to ﬁrst episode psychosis, retrospective reports following
ﬁrst psychotic episode, and quality of life in patients with non-
affective psychosis (Table 6).
An intriguing subset of studies have investigated the link between
sleep dysfunction and psychotic experiences in groups identiﬁed as at
ultra high risk of psychosis. Ruhrmann et al., 2010) utilised the sleepdis-
turbance item from the Structured Interview for Prodromal Symptoms
(SIPS; Miller et al., 1999) as one of six predictors in a model predicting
transition to psychosis from a high risk state. This resulting model pre-
dicted transition to psychosis over 18 months with a sensitivity of
Table 6
Studies addressing the link between sleep and clinical course of psychosis.
Citation Design N Sample characteristics Psychosis measure(s) Sleep dysfunction
measure(s)
Comment on ﬁndings Linked?
Afonso, Brissos,
et al. (2011)
Cross sectional 23 Patients with schizophrenia
(outpatients)
Positive symptoms
PANSS (used to divide into
predominant positive
(n = 11) and predominant
negative (n = 12) groups)
Subjective sleep quality
PSQI
Circadian sleep measures
Wrist actigraphy (7 days
continuous)
Patients with more positive
symptoms report reduced sleep
quality and quality of life in
comparison to patients with
predominantly negative
symptoms.
Y
Afonso et al.
(2014)
Cross sectional a) 34
b) 24
a) Patients with schizo-
phrenia (outpatients)
b) Age and gender matched
non-clinical controls
Positive symptoms
PANSS
Subjective sleep
PSQI
Circadian measures
Wrist actigraphy
Negative correlation found
between positive symptoms
and self-reported sleep quality
in patient group.
Y
Birchwood
et al. (1989)
Longitudinal 19 Patients with schizophrenia
(outpatients)
Positive symptoms
PAS (repeated monthly)
Relapse (deﬁned as
readmission or incipient
readmission)
Subjective sleep
ESS (repeated every
2 weeks for 18 weeks)
Sleep disruption item formed
part of self-report scale
predicting relapse — sleep
disruption reported prior to
positive symptoms on PAS.
Y
Jørgensen
(1998a)
Longitudinal 60 Patients with schizophrenia
(outpatients)
Positive symptoms
Psychotic scale of PANSS
(repeated every 2 weeks
for 6 months or to relapse),
relapse deﬁned as increase
in 2 in any item
Subjective sleep
ESS (repeated every
2 weeks for 6 months or
to relapse)
Increase of 10 points on ESS
predicted relapse with
sensitivity of 81% and
selectivity of 79%.
Y
Jørgensen
(1998b)
Longitudinal 131 Patients with schizophrenia
(outpatients)
Positive symptoms
Psychotic scale of PANSS
(repeated every 2 weeks),
delusion relapse deﬁned as
increase of 2 in delusions
scale
Subjective sleep
WSS (repeated every
2 weeks for 6 months or
to relapse)
8-item Warning Signals Scale
(condensed from ESS found to
have sensitivity of 77% and
speciﬁcity of 68% in detecting
delusion formation.
Y
Kim, Lee, Kim,
Jung, and Lee
(2009)
Retrospective 20 Patients with ﬁrst episode
psychosis
Psychotic symptoms
K-NOS (Korean version)
Subjective sleep
K-NOS (Korean version)
Sleep changes reported in
prodrome of 16–43% of patients.
Y
Lunsford-Avery
et al. (2013)
Cross sectional a) 33
b) 33
a) Adolescents
(aged 12–21 years)
b) Satisfying UHR criteria
c) Age matched non-
clinical controls
Prodromal positive
symptoms
SIPS
SCID
Subjective sleep
PSQI
Sleep dysfunction associated
with negative symptom
severity but not positive
symptoms.
N
Lunsford-Avery
et al. (2015)
Longitudinal a) 36
b) 31
a) Ultra high risk youth
b) Non-clinical controls
Psychotic symptoms
SIPS
SCID
(both at baseline and 12
month follow up)
Objective sleep
Wrist actigraphy
Subjective sleep
PSQI
Sleep disturbance associated
with increased positive
symptoms at baseline in
high-risk group, and predict
clinical symptoms at 12 months
when controlling for age,
depression and baseline
psychotic symptoms.
Y
Martin et al.
(2001)
Cross-sectional 28 Older patients with
schizophrenia (mean
age = 58 yrs)
Positive symptoms
BPRS
SAPS
Objective sleep
Wrist actigraphy (activity
and light exposure)
No clinical or demographic
variables were related to sleep
wake characteristics.
N
Mattai et al.
(2006)
Manipulation
(observed over
medication
wash out period
of 5–7 days)
61 Patients with childhood
onset schizophrenia (mean
age = 10 yrs)
Positive symptoms
BPRS
SAPS
Sleep duration
Nursing notes and safety
records — used to divide
sample into good sleepers
(N6 h sleep) and poor
sleepers (b6 h sleep)
Poor sleepers had signiﬁcantly
increased positive symptoms
scores in comparison to good
sleepers.
Y
Ritsner et al.
(2004)
Cross sectional 145 Patients with schizophrenia
(inpatient and outpatient)
Positive symptoms
PANSS
Subjective sleep
PSQI — used to split
sample into good sleepers
(b5, n = 79) and bad
sleepers (N= 5, n = 66))
No signiﬁcant difference in
positive or negative symptoms
across the good sleeper and
poor sleeper groups.
N
Ruhrmann
et al. (2010)
Longitudinal 245 Youth satisfying ultra high
risk criteria or basic
symptom based criterion
cognitive disturbances
Prodromal positive
symptoms
SIPS
Subjective sleep
SIPS (sleep disturbance
item);
Model predicting transition
from high risk status includes
sleep disturbance as one of 6
predictors, predicts 18 month
outcomes with sensitivity of
41.7% and speciﬁcity of 97.9%.
Y
Tan and Ang
(2001)
Retrospective a) 30
b) 34
Patients in military hospital
with:
a) ﬁrst episode psychosis
b) ﬁrst episode non-
psychotic and non-
organic psychiatric
conditions
Positive symptoms
Unstructured and semi-
structured interviews of
patients and informants
Subjective sleep
Unstructured and semi-
structured interviews of
patients and informants
Sleep disruption seen in
prodrome of 77% of psychotic
patients, but 97% of
non-psychotic.
Y
Xiang et al. Cross sectional 505 Outpatients with Positive symptoms Insomnia symptoms 36% of sample classiﬁed as ‘poor Y
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Table 6 (continued)
Citation Design N Sample characteristics Psychosis measure(s) Sleep dysfunction
measure(s)
Comment on ﬁndings Linked?
(2009) schizophrenia BPRS 3 DSM-IV based items —
classiﬁcation as ‘poor
sleeper’ following
positive answer to 1 item
or more
sleepers’. Poor sleep
signiﬁcantly associated with
positive symptom severity and
reduced quality of life.
BPRS=Brief Psychiatric Rating Scale (Overall & Gorham, 1962); ESS= Early Signs Scale (Birchwood et al., 1989); G-PTS=Green et al. Paranoid Thoughts Scale (Green et al., 2008); ISI=
Insomnia Severity Index (Morin, 1993); K-NOS = Korean version of the Nottingham Interview Schedule (Kim et al., 2009); PANSS = Positive and Negative Symptom Scale (Kay et al.,
1987); PAS=Psychiatric Assessment Scale (Krawiecka, Goldberg, & Vaughan, 1977); PSQI= Pittsburgh Sleep Quality Index (Buysse et al., 1989); SAPS= Scale for Assessment of Positive
Symptoms (Andreasen, 1984); PSYRATS= Psychotic Symptom Rating Scales (Haddock et al., 1999); SCID= Structured Clinical Interview for DSM-IV Disorder (First et al., 1997); SIPS=
Structured Interview for Prodromal Symptoms (Miller et al., 1999); SLEEP-50 = (Spoormaker et al., 2005); WSS =Warning Signals Scale (Jørgensen, 1998b).
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found that several actigraphically measured sleep variables (including
decreased sleep efﬁciency and waking after sleep onset) were predic-
tive of positive psychotic symptoms at baseline and 12 month follow
up. An earlier cross-sectional study from the same authors on a similar
sample (recording only self-reported sleep disruption) found an associ-
ation with negative symptoms but not positive symptoms (Lunsford-
Avery et al., 2013).
Retrospective reports similarly indicate that sleep dysfunction is no-
table before transition to ﬁrst episode psychosis. Tan and Ang (2001)
surveyed the most commonly reported prodromal symptoms across a
group of ﬁrst episode non-psychotic (major depression or anxiety
disorders) and psychotic disorder inpatients at a military hospital.
Sleep disruption was one of the most common symptoms reported in
the prodrome of psychotic disorders (77%), although this is non-
speciﬁc as sleep disruption was even more common (97%) in the non-
psychotic clinical group.
Sleep disruption is also known to be a common symptomprior to re-
lapse, accounting for its typical inclusion in scales developed to predictTable 7a
Studies addressing the link between sleep disorders or sleep disorder symptoms and psychosi
Citation Design N Sample characteristics Psych
measu
Freeman et al.
(2009)
Cross sectional a) 300
b) 30
a) Non-clinical community sample
b) Individuals with persecutory
delusions and diagnosis of
non-affective psychosis.
Paran
G-PTS
Michels et al.
(2014)
Cross-sectional a) 17
b) 14
c) 17
d) 29
a) Inpatients with schizophrenia
b) ARMS outpatients
c) Non-clinical relatives of patients
with schizophrenia
d) Non-clinical controls
Positiv
sympt
PANSS
Palmese et al.
(2011)
Cross-sectional 175 Patients with schizophrenia or
schizoaffective disorder (outpatients)
Positiv
sympt
CGI
(Sheaves,
Onwumere,
et al., 2015)
Cross sectional 40 Patients with psychotic symptoms
(inpatient and outpatient)
Psycho
experi
PSYRA
Xiang et al.
(2009)
Cross sectional 505 Outpatients with schizophrenia Positiv
sympt
BPRS
ARMS= At Risk Mental State (Rausch et al., 2013); BPRS= Brief Psychiatric Rating Scale (Ove
Green et al. Paranoid Thoughts Scale (Green et al., 2008); ISI = Insomnia Severity Index (Morin
Quality Index (Buysse et al., 1989); PSYRATS = Psychotic Symptom Rating Scales (Haddock etrelapse in psychotic populations. The 34-item Early Signs Scale (ESS),
which includes an item on recent sleep disruption, has demonstrated
reasonable sensitivity (81%) and selectivity (79%) in identifying individ-
uals who go on to relapse (Birchwood et al., 1989; Jørgensen, 1998a).
The Warning Signals Scale, an shortened version of the ESS which re-
tains self-reported sleep disruption as one of 8 items, also demonstrated
acceptable speciﬁcity (68%) and selectivity (77%) in detecting individ-
uals prior to relapse in delusions in a large sample of 131 patients
(Jørgensen, 1998b). These ﬁndings suggest that the presence of sleep
dysfunction is predictive of relapse into psychosis.
Sleep has also been linked to the broader well-being of individuals
with psychosis. Several studies have indicated an association between
the severity of positive psychotic symptoms and poorer sleep quality
and quality of life (Afonso, Brissos, Figueira, & Paiva, 2011; Afonso,
Figueira, & Paiva, 2014), including in a large sample (n = 505) of pa-
tients with schizophrenia (Xiang et al., 2009), although one smaller
study (n= 145) found no direct link between self-reported sleep qual-
ity and positive symptoms (Ritsner, Kurs, Ponizovsky, & Hadjez, 2004).
Reduced sleep duration (as indexed from clinical records during ans.
osis
re(s)
Sleep dysfunction
measure(s)
Comment on ﬁndings Linked?
oia Insomnia symptoms
ISI
Sleep-50
Insomnia associated with
paranoid thinking, relationship
largely accounted for by anxiety
and depression
Y
e
oms
Nightmares
Frequency scale (past 2
months)
Positive symptoms did not
correlate with nightmare
frequency, although nightmares
were more common in ARMS
outpatients and schizophrenic
groups.
N
e
oms
Insomnia symptoms
ISI
PSQI
Night eating
NEQ
No signiﬁcant relationship
between positive symptom score
and insomnia severity. No
relationship reported between
night eating and positive
symptom score
N
tic
ences
TS
Subjective sleep
PSQI
Nightmares
Dream log
High proportion of sample
reported weekly distressing
nightmares, distress associated
with severity of delusions.
Y
e
oms
Insomnia symptoms
3 DSM-IV based
questions —classiﬁed as ‘poor
sleeper’ following positive
screen for N= 1
36% of sample classiﬁed as ‘poor
sleepers’. Poor sleep signiﬁcantly
associated with positive
symptom severity and reduced
quality of life.
Y
rall & Gorham, 1962); CGI = Clinical Global Impression Scale (Haro et al., 2003); G-PTS =
, 1993); NEQ=Night Eating Questionnaire (Allison et al., 2008); PSQI = Pittsburgh Sleep
al., 1999); SLEEP-50 = ((Spoormaker et al., 2005).
Table 7b
Studies addressing the link between positive psychotic symptoms and treatment for sleep disorders.
Citation N Sample characteristics RCT Treatment Psychosis
measure(s)
Sleep dysfunction
measure(s)
Comment on ﬁndings
(Freeman &
Waite et al.,
2015)
50 Outpatients with persistent
persecutory delusions/
hallucinations and
insomnia
Y CBT for insomnia (CBTi — 8
sessions in max 12 weeks)
Psychotic experiences
PSYRATS
PANSS
(pre-treatment, post
treatment, 12 week
follow up)
Insomnia symptoms
ISI
(pre-treatment, post
treatment, 12 week
follow up)
CBT for insomnia led to large
effect size reductions in insomnia
symptoms. Direction of changes to
delusions and hallucinations
unclear.
Kato et al.
(1999)
7 Male outpatients with
schizophrenia
N Change to insomnia
medication
(benzodiazapene to 8
weeks of zopiclone
Positive symptoms
BPRS (pre and post
treatment)
Objective sleep
Polysomnography (pre
and post treatment)
Slow wave sleep improved
following move to zopiclone
treatment, negative symptoms
signiﬁcantly improved (positive
symptoms improved but
non-signiﬁcant)
Kantrowitz
et al. (2010)
8 Inpatients with
schizophrenia and
insomnia
N Insomnia medication
(sodium oxybate — 4
weeks)
Positive symptoms
PANSS
(pre and
post-treatment)
Subjective sleep
PSQI (baseline and
post-treatment)
ESS (baseline and
post-treatment)
Objective sleep
PSG (2 nights at
baseline and last nights
of treatment)
Pharmaceutical treatment of
insomnia improved sleep (large
improvements in SWS time,
reduced sleep latency, and
increased REM latency) and
positive symptoms
Myers et al.
(2011)
15 Outpatients with persistent
persecutory delusions and
insomnia
N CBTi — 4 sessions, over
max 8 weeks
Paranoia
G-PTS
Psychotic symptoms
PSYRATS
Anomalous perceptions
CAPS
(All at pre-treatment,
post-treatment, and one
month follow up)
Insomnia symptoms
ISI
Subjective sleep
PSQI
(All at pre-treatment,
post-treatment, and one
month follow up)
CBTi led to improvements in
insomnia symptoms and
persecutory delusions, with
reductions also observed in
anxiety, depression, and
anomalies of experience.
Tek et al.
(2014)
39 Clinically stable
outpatients with
schizophrenia and
insomnia
Y Insomnia medication
(eszopiclone — 8 weeks)
Positive symptoms
PANSS
(every 2 weeks)
Insomnia symptoms
ISI (weekly)
Subjective sleep
Sleep diary (every day)
Psychotic symptoms showed
greater reduction in the treatment
group (CI — 3.1; 0.4) compared to
the group receiving placebo.
CAPS = Cardiff Anomalous Perceptions Scale (Bell, Halligan, & Ellis, 2006); ESS = Epworth Sleepiness Scale (Johns, 1991); G-PTS = Green et al. Paranoid Thoughts Scale (Green et al.,
2008); ISI = Insomnia Severity Index (Morin, 1993); PANSS = Positive and Negative Symptom Scale (Kay et al., 1987); PSQI = Pittsburgh Sleep Quality Index (Buysse et al., 1989);
PSYRATS = Psychotic Symptom Rating Scales (Haddock et al., 1999).
108 S. Reeve et al. / Clinical Psychology Review 42 (2015) 96–115inpatient stay) was found to be strongly associated with increased pos-
itive symptom severity within a group of patients with childhood-onset
schizophrenia (Mattai et al., 2006).
From these studies it seems likely that sleep dysfunction among in-
dividuals with psychosis is associated with poorer clinical outcomes.
The role of sleep disturbance in predicting transition to ﬁrst episode
psychosis or relapse is especially intriguing. However, the majority of
studies on this topic to date do not attempt to measure the inﬂuence
of sleep on individual psychotic experiences and the measure of sleep
dysfunction is often a single self-report item, limiting further interpreta-
tion of this association.
3.2.4. Sleep disorders and their relationship to psychotic experiences in
clinical groups
Only ﬁve studies identiﬁed by the review directly investigated
whether sleep disorders are associated with positive symptoms or indi-
vidual psychotic experiences (Table 7a).
Freeman et al. (2009) studied the relationship between insomnia
and paranoia in a sample of 30 patients with persecutory delusions
and a community sample of 300 individuals. High rates of insomnia
were seen in the clinical group: 54% of the individuals with persecutory
delusions hadmoderate or severe insomnia, versus 7.4% of the commu-
nity sample. Within each group dimensional measures of paranoia and
insomnia severitywere positively associated,with the relationship part-
ly mediated by depression and anxiety. A larger study on outpatients
with schizophrenia in Hong Kong and Beijing (n= 505) found that pa-
tients reporting oneormore insomnia symptomsexhibitedmore severe
positive symptoms than patients who slept well (Xiang et al., 2009).Severity of depressive symptoms was a signiﬁcant contributor to poor
sleep in this sample. In contrast with the above ﬁndings, Palmese et al.
(2011) found no correlation between insomnia symptoms and positive
symptoms — although insomnia prevalence was again found to be ele-
vated in this group, with only 21% of participants reporting no signiﬁ-
cant sleep difﬁculties.
A high proportion of patients with psychotic disorders have also
been found to experience weekly distressing nightmares: 55% (in com-
parison to a 0.9–6.8% estimated prevalence in the general population)
(Sheaves, Onwumere, et al., 2015). The authors found that the level of
distress associated with the nightmares correlated with the severity of
delusions, with this association remaining signiﬁcant after controlling
for nightmare frequency. Another study reported no association be-
tween nightmare frequency and positive symptoms, although patients
and individuals at high risk for psychosis did show elevated nightmare
frequency compared to controls (Michels et al., 2014).
The above studies are only cross-sectional, and therefore canprovide
no indication about the direction of causal effect. However, four
recently-published trials have begun to address the question ofwhether
improving sleep in patients with schizophrenia would also reduce psy-
chotic experiences, though all are substantially underpowered to ad-
dress the connection adequately (Table 7b).
A double-blinded randomised controlled trial of a pharmacological
treatment for insomnia (eszopiclone) in patients with schizophrenia
found that positive psychotic symptoms showed greater reduction of
insomnia symptoms in the treatment group (CI — 3.1; 0.4) versus the
group receiving placebo (Tek et al., 2014). The conﬁdence interval
indicates the potential impact of the sleep intervention. While
Table 8
Studies addressing the link between treatment of positive psychotic symptoms and sleep.
Citation N Sample characteristics Treatment
manipulation
Psychosis
measure(s)
Sleep dysfunction
measure(s)
Comment on ﬁndings Linked?
Chemerinski
et al.
(2002)
122 Patients with
schizophrenia
Withdrawal of
antipsychotic
medication
Positive symptoms
SAPS (weekly)
Insomnia symptoms
HAM-D insomnia
items (weekly)
Patients reporting insomnia prior to
withdrawal had more severe psychotic
symptoms during medication-free period
Y
Neylan et al.
(1992)
18 Clinically stable
patients with
schizophrenia
inpatients
Withdrawal of
antipsychotic
medication
Positive symptoms
Bunney–Hamburg
(daily)
Objective sleep
PSG (3 nights pre and
post withdrawal)
Psychosis scale score correlated with REM
time, inversely correlated with REM onset
latency. This did not predict status following
withdrawal of antipsychotic
Increased symptoms after withdrawal were
associated with reduced sleep continuity and
decrease in total REM and NREM time.
Y
Nofzinger
et al.
(1993)
10 Male patients with
schizophrenia
Withdrawal of
antipsychotic
medication
Positive symptoms
BPRS (at 2 weeks
and 6 weeks post
withdrawal)
Objective sleep
PSG (3 nights at
2 weeks and 6 weeks
post withdrawal)
Changes in EEG sleep during withdrawal
period did not correlate with positive
symptoms.
N
Taylor,
Tandon,
Shipley,
and Eiser,
(1991)
14 Inpatients with
schizophrenia
Administered
antipsychotic
medication
(medication free at
baseline)
Positive symptoms
BPRS (pre-treatment
and after average of
24.4 days of
treatment)
Objective sleep
PSG (one night
pre-treatment and
two nights after
average of 24.4 days
of treatment)
Positive symptoms correlate with shortened
REM latency prior to antipsychotic treatment,
but no symptom measure and sleep variable
correlations found after treatment.
Y
Yamashita
et al.
(2004)
92 Inpatients with
schizophrenia — same
sample as (Yamashita
et al., 2005), average
age 61.5
Observed over
change from
conventional to
atypical
antipsychotics
Positive symptoms
PANSS (baseline and
8 weeks post change
completion)
Subjective sleep
PSQI (baseline and
8 weeks post change
completion)
Improvement in negative symptoms
signiﬁcantly correlated with improvement in
PSQI scores, trend correlation (p = 0.08)
with positive symptoms following
medication switch.
Y
Yamashita
et al.
(2005)
a) 35
b) 51
Inpatients with
schizophrenia:
a) Elderly (age ≥ 65)
b) Middle-aged
(age b 65)
Observed over
change from
conventional to
atypical
antipsychotics
Positive symptoms
PANSS (baseline and
8 weeks post change
completion)
Subjective sleep
PSQI (baseline, and
8 weeks post
completion of
change)
Improvement in sleep satisfaction was
signiﬁcantly correlated with improvement in
all subscales of the PANSS (including positive
symptoms), but only in the middle aged
group. Correlation limited to negative
symptoms and self-rated sleep quality in
elderly group.
Y
Zhang et al.
(2012)
a) 40
b) 18
First episode psychosis
patients
a) Electroconvulsive
therapy and
antipsychotic
medication
b) Antipsychotic
medication only
Positive symptoms
PANSS (baseline and
then repeated
weekly during
hospital stay)
Objective sleep
PSG (overnight,
recorded at baseline
and week 2)
Reduction in positive symptoms signiﬁcantly
correlated with improvements in sleep
efﬁciency, REM latency, and REM density.
Sleep efﬁciency and positive symptoms
improved further from baseline in the ECT
and antipsychotic group versus the
antipsychotic only group.
Y
SAPS = Scale for Assessment of Positive Symptoms (Andreasen, 1984); HAM-D= Hamilton Depression Rating Scale (Hamilton, 1960); Bunney–Hamburg Scale (Bunney & Hamburg,
1963); PSG = Polysomnography (see Tables 1a for deﬁnition); BPRS = Brief Psychiatric Rating Scale (Overall & Gorham, 1962); PANSS = Positive and Negative Symptom Scale (Kay
et al., 1987).
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derpowered to produce effects signiﬁcant at conventional levels (Lee,
Whitehead, Jacques, & Julious, 2014). Furthermore only 39 of the
intended sample of 80 were recruited, which will have further reduced
the study power.
An open-label non-randomised trial of a pharmacological interven-
tion (sodium oxybate) for insomnia on a small sample (n= 8) of inpa-
tients with schizophrenia (Kantrowitz et al., 2010) found large effect
size improvements in several PSG sleep variables (including an increase
in SWS time and REM onset latency), an improvement in self-rated
sleep quality, and a reduction in total Positive and Negative Symptom
Scale score (PANSS; Kay, Fiszbein, & Opfer, 1987). However, there was
no reported signiﬁcant speciﬁc effect on the positive symptoms sub-
scale, and the reported outcomes do not provide mean changes or con-
ﬁdence intervals.
A case series study of cognitive behavioural therapy for insomnia
(CBTi) trial reported a clear improvement in psychotic experiences
and sleep. 15 outpatients with persecutory delusions received 4 ses-
sions of CBTi in an un-blinded uncontrolled trial (Myers et al., 2011).
In this case, large effect size improvements in insomnia symptoms and
persecutory delusions were observed with reductions also observed in
anxiety, depression, and anomalies of experience. A subsequent
single-blind randomised controlled trial testing the efﬁcacy of CBT for
sleep problems in 50 patients with persistent delusions and hallucina-
tions has been completed (Freeman & Waite et al., 2015). CBT washighly efﬁcacious in improving insomnia in this population (Cohen's d
effect size = 1.9), but was inconclusive about the impact of this treat-
ment on psychotic experiences because of the sample size.
3.2.5. Sleep and treatment for psychosis
A number of studies indicate that improvement in symptoms fol-
lowing antipsychotic treatment is associated with improvement in
sleep variables (Taylor, Tandon, Shipley, & Eiser, 1991; Yamashita
et al., 2004, 2005). Sleep dysfunction may also predict poorer clinical
outcome following medication withdrawal (Chemerinski et al.,
2002; Neylan, van Kammen, Kelley, & Peters, 1992), although in
one smaller study sleep variables displayed no relationship with
clinical symptoms (Nofzinger, van Kammen, Gilbertson, Gurklis, &
Peters, 1993).
On balance such studies do appear to support an association be-
tween changes in positive psychotic symptoms and sleep. However,
in this context it is difﬁcult to associate any changes reported in
sleep variables directly to changes in symptoms due to the likely di-
rect of antipsychotic medication on sleep via their inﬂuence on
multiple neurotransmitter systems (Cohrs, 2008). This effect partic-
ularly complicates interpretation of studies on the impact of with-
drawing or changing antipsychotic medications such as those
described here.
A recent randomised controlled trial indicated that improvement in
positive psychotic symptoms following electroconvulsive therapy (ECT)
110 S. Reeve et al. / Clinical Psychology Review 42 (2015) 96–115is associated with an improvement in sleep variables (Zhang et al.,
2012). The magnitude of reduction in positive symptoms following
ECT signiﬁcantly correlated with increases in sleep efﬁciency, REM
onset latency, and REM density. Furthermore, sleep efﬁciency and pos-
itive psychotic symptoms improved further in the groupwhich received
ECT in addition to treatment as usual (antipsychotic medication) com-
pared to a control group receiving only treatment as usual. The method
of action of ECT on psychosis or sleep remains unclear (N. Kato, 2009)
although it has been proposed that the mechanism of action of ECT is
to mimic the EEG characteristics of slow wave/delta sleep (Charlton,
1999).4. Discussion
There are surprisingly few studies that have assessed both individual
psychotic experiences and sleep dysfunction. Currently the best quality
evidence is in non-clinical populations, primarily utilising subjective re-
ports of sleep. Here there is convincing evidence that psychotic experi-
ences and sleep dysfunction co-occur (especially with respect to
insomnia and paranoia). Yet this does not elucidate the direction of
causal effects. There are fewer studies testing longitudinal data, but
those that exist do indicate that sleep dysfunction (particularly symp-
toms of insomnia and nightmares) predicts later psychotic experiences.
The opposite direction of causation (i.e. whether psychotic experiences
predict later sleep dysfunction) remains to be tested. Evidence fromma-
nipulation studies, the strongest research design, is so far limited to
sleep deprivation protocols using small sample sizes. Regardless, these
studies do indicate that reducing sleep elicits psychotic-like experi-
ences, as consistentwith a causal role for sleep dysfunction in psychosis.
The clear next step for manipulation studies in the general popula-
tion would be to test whether treatment of insomnia affects the occur-
rence of psychotic experiences. Such a study is already underway
(Freeman & Sheaves et al., 2015). Another focus for future research in
non-clinical populationswould be to determine themechanismsunder-
lying the association between sleep and psychotic experiences. Anxiety
and depression are consistently found to act as partial mediators, but
these are typically the only potential mediating factors tested. Further-
more, assessment of sleep dysfunction should not always be restricted
to insomnia given the broader association with other sleep disorders
such as parasomnias reported here.
The studies in clinical populations are so far less conclusive. Issues
include the heterogeneity of the populations studied (compounded by
small sample sizes), and limited psychotic experiences assessment, al-
though objective sleep assessments such as PSG and actigraphy have
been widely applied — in contrast to the non-clinical studies. It seems
likely that sleep dysfunction and psychotic experiences do co-occur,
and that sleep might be a predictor of clinical change. The ﬁeld requires
much more attention. For instance, assessing a wide variety of sleep
processes in relation to individual psychotic experiences at different
stages in the clinical course of psychotic disorders. Substantial tests of
a potential reciprocal relationship between sleep dysfunction and psy-
chotic experiences are required. Further prospective studies are needed
on the causal role that sleep problems may play in those at high risk of
psychosis, particularly in relation to transition to ﬁrst episode psychosis.
The typical sleep changes in adolescence, in particular exhibiting a pref-
erence for a later chronotype (Gau & Soong, 2003; Gradisar, Gardner, &
Dohnt, 2011; Keyes,Maslowsky, Hamilton, & Schulenberg, 2015) are es-
pecially interesting in this regard, as this is the age at which psychotic
experiences often begin to manifest. More thorough assessments of
sleep at this period of elevated risk would be an advantage for future
studies — in particular, considering individual sleep disorders rather
than single item measures of sleep disturbance. As one example, a re-
cent student population survey found that insomnia, nightmare fre-
quency, and nightmare distress increased risk for mental illness in a
dose–response fashion (Sheaves et al., in press).Importantly, deﬁnitive studies of interventions to improve sleep in
patients with psychotic experiences are needed. Again, this would ide-
ally include tests of treating different types of sleep problems. For in-
stance, there is a substantial case report literature going back more
than 30 years on treatment of sleep apnoea in individuals with psycho-
sis improving positive psychotic symptoms as well as sleep (e.g.
Berrettini, 1980; Bouﬁdis et al., 2003; Chiner, Arriero, Signes-Costa, &
Marco, 2001; Karanti & Landén, 2007; Lee, Chiu, & Chen, 1989), yet no
systematic trials have been undertaken to date (Kalucy et al., 2013;
Waters, Hanken, & Rock, 2013). The small number of such studies, and
the lack of any addressing disorders besides insomnia, is striking given
guidance that co-morbid sleep disorders should receive treatment in
their own right, and the existing indications that improving sleep may
have the beneﬁt of lessening psychotic experiences.
4.1. Theoretical integration
It is likely that further development in the understanding of the con-
nection between sleep and psychosis could be made by integrating the
ﬁndings with the existing theoretical literature in each of the two areas.
Previous studies drawing upon a cognitive model of persecutory de-
lusions (Freeman et al., 2002) have shown that negative affect (anxiety
and depression) may be an important link between sleep and paranoia.
Another shared factor between this model of psychosis and cognitive
models of insomnia that remains to be tested is the thinking style of
worry. Other important routes – such as via anomalous experiences
and reasoning biases – also remain to be investigated. Cognitivemodels
of hallucinations, while yet to be explicitly linked with sleep, have sim-
ilarly emphasised negative affect as having a key role in the source,
form, and content of hallucinatory experiences (Waters et al., 2012).
Furthermore, it is possible that sleep dysfunction could contribute to
cognitive processes associated with hallucinatory experiences such as
changes in source monitoring and inhibitory control. It is also possible
that disturbances in sleep couldmediate the relationship between trau-
ma, PTSD, and hallucinatory experience (Morrison, Frame, & Larkin,
2003).
Parasomnias have historically received less attention than insomnia,
yet indications from this review are that these disorders may have an
important relationship to psychotic experiences, particularly in the
case of nightmares. Dreams and nightmares have a longstanding associ-
ation with psychosis owing to perceived phenomenological similarity
(Limosani, D'Agostino, Manzone, & Scarone, 2011; Mason & Wakerley,
2012). The notion that in both states internally generated images or
ideas are experienced as having an external origin, and as being intrin-
sically believable, has been carried through to modern theorising
(Feinberg, 2011; Hobson, 2004). Cognitive models of nightmares (e.g.
Nielsen & Levin, 2007) provide a link to models of paranoia and halluci-
nations via a shared emphasis on affective disturbance (in particular
anxiety), as well as biases towards negative appraisals, for example of
the nightmare event. Nightmares are most associated with REM sleep
activity, which has been found to have an earlier onset and perhaps
make up a higher percentage of total sleep time in psychotic popula-
tions—with both these characteristics correlating with increased posi-
tive psychotic symptom severity (Sarkar et al., 2010). An intriguing
further direction for this research would be to directly investigate
whether these REM sleep characteristics are associated with nightmare
reports and psychotic experiences in clinical and non-clinical groups.
A neurodevelopmental model of psychosis, where psychosis is seen
as resulting from aberrant synaptic pruning during adolescence, has
been linked to sleep dysfunction in psychosis (Keshavan, Anderson, &
Pettergrew, 1994; Lunsford-Avery & Mittal, 2013). This account pro-
vides a plausible physiological underpinning for sleep dysfunction in
psychosis, as structural abnormalities in key regions for promoting
and maintaining sleep (e.g. the thalamus) are present in patients with
ﬁrst episode and chronic schizophrenia (Adriano, Spoletini,
Caltagirone, & Spalletta, 2010), and in individuals who are at risk of
111S. Reeve et al. / Clinical Psychology Review 42 (2015) 96–115schizophrenia (Lunsford-Avery et al., 2013). In the latter case the tha-
lamic abnormalities were found to predict sleep dysfunction. Further
work based on this model would need to establish a mechanism by
which neurodevelopmental abnormalities or lack of sleep speciﬁcally
lead to the experiences of individual psychotic experiences such as de-
lusions or hallucinations.
Another body of research linking sleep and psychosis focuses on the
impact of dysfunctional circadian rhythms in patients with schizophre-
nia. Studies utilising melatonin proﬁling in patients with schizophrenia
have illuminated a range of circadianmisalignments, such as delayed or
advanced sleep phase, irregular sleep patterns, and free-running rest
and activity patterns (where the circadian phase does not align to
24 h and therefore sleep and wake phases occur at different times
each day) (Bromundt et al., 2011;Wulff et al., 2012). Themelatonin pro-
ﬁle in individuals with schizophrenia has been described as ‘blunted’,
with reduced circadian variation in melatonin secretion, and a reduced
correlation between rise in melatonin and sleep efﬁciency (Afonso,
Figueira, & Paiva, 2011). Two small RCTs have indicated that melatonin
supplements improve sleep quality in patients with schizophrenia
(Kumar, Andrade, Bhakta, & Singh, 2007; Shamir et al., 2000) although
neither investigated the effect of this treatment with psychotic experi-
ences. A particular area of interest is the interaction of melatonin with
dopamine and other key neurotransmitter systems associatedwith psy-
chosis and the action of antipsychotic medications (Anderson & Maes,
2012; Monti et al., 2013). A range of animal studies have shown that
melatonin inhibits dopamine release, increases dopamine turnover,
and alters dopamine receptor activation (Monti et al., 2013), therefore
one inﬂuence of a disturbedmelatonin secretion proﬁle could be the do-
pamine dysregulation thought to represent a ‘ﬁnal commonpathway’ to
psychosis (Howes & Kapur, 2009). Again, further development based
upon thismodel would need to specifymechanisms linked to individual
psychotic experiences.
The salience model of psychosis (Kapur, 2003; Kapur, Mizrahi, & Li,
2005) has been linked to sleep dysfunction via the proposed role of
sleep in synaptic homeostasis (Tononi & Cirelli, 2014). According to
the synaptic homeostasis hypothesis, the need for sleep (or sleep pres-
sure) arises physiologically as a result of synaptic potentiation in wake-
fulness (new connections are constantly made in response to the
environment while awake, but there is no corresponding downscaling
or removing of associations). Slow wave sleep, in this theory, mediates
a downscaling of synaptic strength, allowing informational efﬁciency
to be restored for the next day. This would imply that, if sleep were dis-
turbed as it is in psychosis, downscalingwould be disrupted, and there-
fore the ability of the neural network to correctly detect novel
associations may be disrupted. This would allow abnormal associations
to arise and persist without contextual corrections, and may result in
type 1-style errors in assessing the informational value (or salience) of
these associations. Reports of individuals with psychosis being more
likely to perceive meaning in ambiguous stimuli would support this ac-
count (Catalan et al., 2014; Galdos et al., 2011). On the other hand, the
synaptic homeostasis hypothesis is primarily proposed as a theory of
the function slow wave sleep, whereas the primary sleep architecture
changes directly related to psychosis in the research literature to date
involve REM sleep. Regardless, this theory does provide testable hy-
potheses for future research — for example, does sleep deprivation in
non-clinical individuals cause similar changes in information process-
ing? However the model does not differentiate how this process could
contribute to the emergence of individual psychotic experiences,
which have been shown to have independence from each other (e.g.
Ronald, 2015).
A recent theory of positive psychotic symptoms provides a com-
putational account based on Bayesian inference (Adams, Stephan,
Brown, Frith, & Friston, 2013; Davies & Egan, 2013). Bayesian
conceptualisations of psychosis describe delusions and hallucinations
as both arising from faulty inference. A belief can be heldwith great pre-
cision or conﬁdence — this corresponds to a narrowed variance in theprobability distribution. In Bayesian inference, prior beliefs (or expecta-
tions) are transformed to posterior beliefs by combinationwith the cur-
rent sensory evidence, its perceived accuracy, and the predicted
likelihood of that sensory data occurring given the prior belief. If a
piece of evidence is thought to be accurate, but unlikely given previous
beliefs, these older beliefs will be altered. Such a system can be thought
of as having conﬁdence in the accuracy of an existing belief.
Onemodel based on this theory proposes that psychosis results from
a reduction of this conﬁdence in relation to current sensory evidence
(Adams et al., 2013). An impact of this would be that beliefs or percep-
tions are more malleable in the face of sensory evidence, i.e. there is a
reduced inﬂuence of previous beliefs, due to their estimated low preci-
sion. One example of evidence for this model is that individuals with
schizophrenia have been found to be less susceptible to visual illusions
(Notredame, Pins, Deneve, & Jardri, 2014). As visual illusions work by
capitalising on pre-existing beliefs about the environment, resistance
to visual illusions in individuals with psychosis could be an expression
of reduced inﬂuence of such beliefs. Some studies have reported that
this reduced susceptibility to illusions correlates with the severity of
positive psychotic symptoms (e.g. Silverstein et al., 2013) — and fur-
thermore, sleep deprived non-clinical volunteers have been found to
exhibit a similar resistance to visual illusions (Schmeider, Leweke,
Sternemann, Emrich, & Weber, 1996; Sternemann et al., 1997). Further
development of this model would need to provide an account of
how sleep dysfunction could contribute to this change in inferential
processing — for example, whether sleep dysfunction could contribute
to the dopaminergic modulations that have been suggested as instanti-
ating this computational change in psychosis (Adams et al., 2013;
Castelnovo, Ferrarelli, & D'Agostino, 2015). However, these models
again have the issue of the absence of differentiation between different
psychotic experiences.
In conclusion, we are beginning to see an acknowledgement of the
potential role of sleep in the occurrence of psychotic experiences. It is
now clear from the research that these two phenomena are connected.
The direction of effect is yet to be shown and themechanisms bywhich
sleep and psychotic experiences are linked remain to be established, al-
though there are many plausible different routes for further investiga-
tion. Even if future research indicates no causal connections between
sleep and psychosis, we would argue that the high prevalence of sleep
problems in patients with psychosis should still become a target in clin-
ical services, since it is an important problem in its own right, for which
effective treatments exist (Freeman & Waite et al., 2015). There is cur-
rently a striking absence of systematic research into the treatment of
sleep problems in non-affective psychosis.Role of funding source
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